However, it has been found that in patients with gastric cancer, the levels of serum PD-L1 and the expression of tissue PD-L1 can potentially be used as biomarkers to predict the chances of recurrence and to determine the prognosis [65]. The gene discussed is CD274; the disease is gastric cancer.